Actinium Pharmaceuticals
ATNM
#9134
Rank
โ‚น4.94 B
Marketcap
โ‚น158.52
Share price
2.73%
Change (1 day)
-61.13%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -โ‚น3.9 Billion

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.08 Million. In 2023 the company made an earning of -โ‚น4.38 Billion a decrease over its 2022 earnings that were of -โ‚น2.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น3.9 Billion-11.14%
2023 -โ‚น4.38 Billion52.24%
2022 -โ‚น2.88 Billion36.61%
2021 -โ‚น2.11 Billion11.48%
2020 -โ‚น1.89 Billion1.46%
2019 -โ‚น1.87 Billion-7.37%
2018 -โ‚น2.01 Billion-11.46%
2017 -โ‚น2.27 Billion10.67%
2016 -โ‚น2.06 Billion15.7%
2015 -โ‚น1.78 Billion-14.86%
2014 -โ‚น2.09 Billion129.19%
2013 -โ‚น0.91 Billion-8.55%
2012 -โ‚น1 Billion
2010 โ‚น0.69 M-152.15%
2009 -โ‚น1.35 Million-39.8%
2008 -โ‚น2.23 Million120.29%
2007 -โ‚น1.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น3.14 Billion-20.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น33.00 B-938.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น8.42 Billion 113.75%๐Ÿ‡บ๐Ÿ‡ธ USA